Valiant Organics Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹204Cr
- +15.3% YoY
- +9.1% QoQ
- Net profit
- ₹4Cr
- Turned profitable YoY
- −20% QoQ
- Margin
- 10%
- +11.2 pp YoY
- +2 pp QoQ
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Valiant Organics Ltd's Q4 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10). Q4 FY25 Consolidated Financials (Page 12 & 9): - EBITDA: INR 203 Mn, up from INR (18) Mn in Q4 FY24 (YoY positive turnaround) - EBITDA Margin: 9.96%, improved from -1.02% in Q4 FY24 (YoY improvement of 1,098 bps) - PAT: INR 42 Mn, up from INR (202) Mn in Q4 FY24 (significant YoY recovery) - PAT Margin: 2.06%, versus -11.43% in Q4 FY24 (YoY positive turnaround) - EPS (Basic/Diluted): INR 1.52/share, compared to (3.81) in Q4 FY24 - Explicit Margin Outlook:
From Valiant Organics Ltd's Q4 FY25 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10).
- Key chemistries sales volumes (MT) for Q4-FY25:
- Chlorination: 379 MT (up from 360 MT in Q4-FY24)
- Hydrogenation: 1,126 MT (up from 879 MT in Q4-FY24)
- Ammonolysis: 458 MT (down from 513 MT in Q4-FY24) (Page 11)
2 more points from Valiant Organics Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Valiant Organics Ltd said on order book & pipeline — free account, 30 seconds.
Valiant Organics Ltd — Quarterly revenue & net profit
Valiant Organics Ltd Q4 FY25 results — key figures
| ₹ Cr | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 204 | 177 | +15.3% | 187 | +9.1% |
| Operating profit (EBITDA) | 21 | -2 | — | 15 | +40% |
| Operating margin | 10% | -1.2% | +11.2 pp | 8% | +2 pp |
| Profit before tax | 7 | -25 | — | 6 | +16.7% |
| Net profit (PAT) | 4 | -20 | — | 5 | -20% |
| EPS (₹) | 1.50 | -7.32 | — | 1.98 | -24.2% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹304 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Valiant Organics's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Atul (Q4 FY25)
Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). Key concall takeaways from Atul Ltd's Q4…
- Vidhi Specialty (Q4 FY25)
109.5 Crs, up 40.2% YoY (from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 earnings call — and how it ranks against sector…
- Chemcon Speciality Chemicals (Q4 FY25)
54.9 Crs, down 8% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Clean Science (Q4 FY25)
2,500 crores to Rs. Key concall takeaways from Clean Science's Q4 FY25 earnings call — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Valiant Organics Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Valiant Organics Ltd Q4 FY25 results?
Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10). Q4 FY25 Consolidated Financials (Page 12 & 9): - EBITDA: INR 203 Mn, up from INR (18) Mn in Q4 FY24 (YoY positive turnaround) - EBITDA Margin: 9.96%, improved from -1.02% in Q4 FY24 (YoY improvement of 1,098 bps) - PAT: INR 42 Mn, up from INR (202) Mn in Q4 FY24 (significant YoY recovery) - PAT Margin: 2.06%, versus -11.43% in Q4 FY24 (YoY positive turnaround) - EPS (Basic/Diluted): INR 1.52/share, compared to (3.81) in Q4 FY24 - Explicit Margin Outlook:
What is Valiant Organics Ltd share price analysis?
Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
